Cleared Traditional

K133896 - REJUVALITE MD (FDA 510(k) Clearance)

Class II General & Plastic Surgery device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2014
Decision
328d
Days
Class 2
Risk

K133896 is an FDA 510(k) clearance for the REJUVALITE MD. Classified as Light Based Over The Counter Wrinkle Reduction (product code OHS), Class II - Special Controls.

Submitted by Trophy Skin, Inc. (Coralville, US). The FDA issued a Cleared decision on November 13, 2014 after a review of 328 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the General & Plastic Surgery FDA review panel, regulated under 21 CFR 878.4810 - the FDA general and plastic surgery device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the General & Plastic Surgery review framework, consistent with the majority of Class II 510(k) submissions.

View all Trophy Skin, Inc. devices

Submission Details

510(k) Number K133896 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 20, 2013
Decision Date November 13, 2014
Days to Decision 328 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
214d slower than avg
Panel avg: 114d · This submission: 328d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code OHS Light Based Over The Counter Wrinkle Reduction
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 878.4810
Definition Use Of Light Based Treatment To Reduce Wrinkles On The Body In General Or Specific Anatomical Locations Depending On The Information Provided.
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General & Plastic Surgery devices follow this clearance model.

Regulatory Peers - OHS Light Based Over The Counter Wrinkle Reduction

All 148
Devices cleared under the same product code (OHS) and FDA review panel - the closest regulatory comparables to K133896.
LED FACIAL MASK (MJ-66DB, MK-99, MK-99A, MK-99M, MJ-66C)
K260150 · NOOANCE · Apr 2026
LED Light Therapy Masks (LumiLips FAC07NA)
K260202 · Guangdong Newdermo Biotech Co., Ltd. · Mar 2026
LED Light Therapy Mask (Models: T2, RLD10)
K254079 · Shenzhen Desida Technology Co., Ltd. · Mar 2026
Ulike Reglow Light Therapy Device (UM10)
K260511 · Shenzhen Ulike Smart Electronics Co., Ltd. · Mar 2026
LED Therapy Light (COB1400, HP1800PRO)
K253874 · Shenzhen Hanhua Opto Co., Ltd. · Mar 2026
FAQ™ (LED Panel)
K253683 · Foreo, Inc. · Feb 2026